News

Our Healthcare News

Corium Reports Third Quarter Fiscal 2015 Financial Results

MENLO PARK, California—Corium International, Inc. (Nasdaq: CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced unaudited…  

Jul 29 2015

Corium Announces Positive Topline Results from Phase 2a Study of Transdermal MicroCor PTH

MENLO PARK, California—Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical
company focused on the development, manufacture and commercialization of specialty transdermal products, today announced positive…  

Jul 28 2015

Corium Co-Founder Dr. Gary W. Cleary Honored with Controlled Release Society Founders Award

MENLO PARK, California—Corium International, Inc. (NASDAQ:  CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, announced today that…  

Jul 27 2015

Allergan Strengthens DARPin Development and Discovery Alliance with Molecular Partners

ZURICH-SCHLIEREN, Switzerland—Molecular Partners AG (ticker: MOLN) today announced that Allergan, Inc. has reinforced its broad commitment to the discovery, research and development of multiple DARPin‐based…  

Jul 21 2015

Catalyst Biosciences Announces Positive Results From a Phase I Clinical Trial

SOUTH SAN FRANCISCO, California (GLOBE NEWSWIRE)—Catalyst Biosciences, Inc., a privately held biopharmaceutical company, today announced positive results from a Phase 1 clinical trial of CB…  

Jun 24 2015

Open Monoclonal Technology Announces OmniAb Alliance with Amgen

PALO ALTO, California—Open Monoclonal Technology, Inc. (OMT) today announced a license that provides Amgen Inc. with access to OMT’s proprietary OmniRat®, OmniMouse® and OmniFlic™ human…  

Jun 15 2015

US Food and Drug Administration Accepts Biologics License Application for Anthim (Obiltoxaximab)

PINE BROOK, New Jersey– Elusys Therapeutics, Inc. (Elusys) today announced the U.S. Food and Drug Administration (FDA) has accepted for filing and review its Biologics…  

Jun 03 2015

Entellus Medical Announces European Launch of XprESS (TM) LoProfile Multi-Sinus Dilation System

PLYMOUTH, Minnesota (GLOBE NEWSWIRE)—Entellus Medical, Inc. (Nasdaq:ENTL), a medical technology company focused on designing, developing and commercializing products for the minimally invasive treatment of chronic…  

Jun 01 2015

Encore Dermatology, Inc.  A New Specialty Dermatology Company

MALVERN, Pennsylvania—(BUSINESS WIRE)—Encore Dermatology, Inc. announced today that it has begun to commercialize Hylatopic, Tetrix, and BenzEFoam, three highly regarded and established US topical dermatology…  

May 18 2015